Conference abstract · 1 Dec 2016
Conference abstractPublished 2018
Brain injury mitigation by endocannabinoid modulators
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Stroke and Traumatic Brain Injury (TBI) are a major cause of mortality, morbidity and disability. Current therapy is limited with no significant improvement in the last 10 years. Recent discoveries in TBI indicate the newly identified endocannabinoid system plays a major role in orchestrating patient neurologic injury and recovery. Natural cannabinoids and associated molecules offer significant neuroprotection with little risk of adverse effects. Cannabinoids and terpenoids are contained in many plant species including hops, flax and hemp. A 2014 study of 446 TBI events found a 78% reduction in death for those with evidence of cannabinoid use. Preclinical studies in stroke models have reported protective effects of cannabidiol from hemp up to 6 hours after an acute event. The pharmaceutical industry has failed to bring to market a safe or effective synthetic cannabinoid modulating drug over the last decade. In contradistinction, natural cannabinoids of cannabidiol and tetra-hydro cannabinol are effective for multiple conditions and pending FDA approval. New protocols for the use of natural cannabinoid combinations are urgently needed immediately as part of a comprehensive strategic approach to stroke and TBI.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 1 Oct 2018
Traumatic brain injury: Secondary brain injury management and the mitigation of cognitive, psychological and physical impairment
Conference abstract · 31 Oct 2024
Neuroprotective effect of tangeretin against Potassium dichromate induced acute brain injury in rats via modulating the Nrf2 signaling pathway and quenching the release of inflammatory mediators and apoptosis in rats
Case report · 30 Sep 2024
Immune System Modulation in Traumatic Brain Injury: Understanding Neuroimmune Pathways
Conference abstract · 12 Sep 2016
The NG2 proteoglycan is an endogenous modulator of adverse glial responses and counteracts neurological deficits following traumatic brain injury
More from this journal
The newest in Journal of Neurology & Neurophysiology.
Article · 31 Mar 2025
Neural coding and sensory integration in somatosensory cortex
Conference abstract · 3 Feb 2025
The Most common cause of falls without cause in geriatric patients
Conference abstract · 3 Feb 2025
Neuroimaging by Evaluation Nerverenovate and Neuroplasticity of Acupuncture in Children with Cerebral Palsy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neurology & Neurophysiology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Philip Blair”

